1-2 of 2
Germing Ulrich, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytogenetic Remission Status after Induction Chemotherapy for AML and High-Risk MDS Predicts Long-Term Outcome.

Sebastian Balleisen, MD, Hildebrand Barbara, PhD, Royer-Prokora Brigitte, PhD, Kuendgen Andrea, MD, Gattermann Norbert, MD, Germing Ulrich, MD, Haas Rainer, MD
Journal: Blood
Blood (2004) 104 (11): 3009.
https://doi.org/10.1182/blood.V104.11.3009.3009
Published: 2004
Journal Articles

Results of a Phase 2 Trial with Valproic Acid Alone or in Combination with All-Trans-Retinoic Acid (ATRA) in 29 Patients with Myelodysplastic Syndromes.

Kuendgen Andrea, MD, Strupp Corinna, MD, Hildebrandt Barbara, PhD, Knipp Sabine, MD, Junge Baerbel, Haas Rainer, MD, Germing Ulrich, MD, Gattermann Norbert, MD
Journal: Blood
Blood (2004) 104 (11): 1434.
https://doi.org/10.1182/blood.V104.11.1434.1434
Published: 2004